Prediction of outcomes in MCI with 123I-IMP-CBF SPECT: a multicenter prospective cohort study

Kengo Ito,Etsuro Mori,Hidenao Fukuyama,Kazunari Ishii,Yukihiko Washimi,Takashi Asada,Satoru Mori,Kenichi Meguro,Shin Kitamura,Haruo Hanyu,Seigo Nakano,Hiroshi Matsuda,Yasuo Kuwabara,Kazuo Hashikawa,Toshimitsu Momose,Yoshitaka Uchida,Jun Hatazawa,Satoshi Minoshima,Kenji Kosaka,Tatsuo Yamada,Yoshiharu Yonekura

Prediction of outcomes in MCI with 123I-IMP-CBF SPECT: a multicenter prospective cohort study

2013

Objective The multicenter prospective cohort study (Japan Cooperative SPECT Study on Assessment of Mild Impairment of Cognitive Function: J-COSMIC) aimed to examine the value of 123I-N-isopropyl-4-iodoamphetamine cerebral blood flow (IMP-CBF) SPECT in regards to early diagnosis of Alzheimer’s disease (AD) in patients with mild cognitive impairment (MCI).

Keywords:

Internal medicine
Prospective cohort study
Cardiology
Pediatrics
Cohort study
Cerebral blood flow
Disease
Cognition
Surgery
Cerebrovascular Circulation
Medicine
in patient
cognitive impairment
123i imp

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations